 |
|
| ANNUAL REPORTS IN MEDICINAL CHEMISTRY, 39
| |
| | |
|
|
 To order this title, and for more information, click here
Edited By
Annette Doherty, Pfizer Global R&D, Sandwich Laboratories, United Kingdom
Description
Annual Reports in Medicinal Chemistry continues to focus on providing timely and critical reviews of important topics in medicinal
chemistry together with an emphasis on emerging topics in the biological sciences, which are expected to provide the basis for entirely
new future therapies.
Sections I-IV are disease orientated and generally report on specific medicinal agents.
Sections V and
VI continue to emphasize important topics in medicinal chemistry, biology, and drug design.
Audience
For medicinal, pharmaceutical and organic chemists.
Contents
I. CENTRAL NERVOUS SYSTEM DISEASES
1. Attention Deficit Hyperactivity Disorder: Pathophysiology and Design of New Treatments
(S.A. Glase, D.J. Dooley).
2. Ionotropic GABA Receptors as Therapeutic Targets for Memory and Sleep Disorders (M. Chebib et
al.).
3. Melatonin Agonists for the Treatment of Sleep Disorders and Major Depression (L.R. Fitzgerald, J.E. Reed).
II.
CARDIOVASCULAR AND METABOLIC DISEASES
4. Recent Advances in Therapeutic Approaches to Type 2 Diabetes (Ramakanth Sarabu, J. Tilley).
5. Recent Progress in Histamine H3 Receptor Chemistry (R. Aslanian, Neng-Yang Shih).
6. Anti-Resorptive and Anabolic Bone Agents
(G.D. Hartman, R.S. Meissner).
7. Inhibition of the Cysteine Protease Cathepsin-K (EC 3.4.22.38)(R.W. Marquis).
8. Nonpeptide
Gonadotropin Releasing Hormone Antagonists (Yun-Fei Zhu et al.).
III. INFLAMMATORY, PULMONARY, AND GASTROINTESTINAL
DISEASES
9. Bradykinin B2 Antagonists for the Treatment of Pain (E.K. Dziadulewicz).
10. Selective Cyclooyxgenase-2 Inhibitors
(W. Cameron Black).
11. The Discovery of Small Molecule C5a Antagonists (A.J. Hutchison, J.E. Krause).
12. CCR1 Antagonists
(K.G. Carson et al.).
IV. CANCER AND INFECTIOUS DISEASES
13. Recent Advances in Antimetabolite Cancer Chemotherapies
(J.R. Henry, M.M. Mader).
14. Mitotic Kinesin Inhibitors as Novel Anticancer Agents (K.W. Wood, G. Bergnes).
15. Recent Advances
in Medicinal Chemistry of Histone Deacetylase Inhibitors (H. Weinmann, E. Ottow).
16. Therapeutic Opportunities for the Treatment
of Biofilm-Associated Infections (Zhenkun Ma et al.).
17. Biowarfare Pathogens. Is the Research Flavor Different Than That
of Clinically Relevant Pathogens? (Ving J. Lee).
18. HCV Antiviral Agents (R.C. Griffith et al.).
V. TOPICS IN BIOLOGY
19. Pleiotropic Effects of Statins (A. Floto et al.).
20. Comparative Protein Structure Modeling and Its Applications
to Drug Discovery (M. Jacobson, A. Sali).
VI. TOPICS IN DRUG DESIGN AND DISCOVERY
21. Drug Transporters and Their Role
in Tissue Distribution (A.H. Dantzig).
22. The Hit-to-Lead Process in Drug Discovery (P. Gillespie, R.A. Goodnow, Jr.).
23. Prodrug
Strategies in the Design of Nucleoside and Nucleotide Antiviral Therapeutics (R.L Mackman, T. Cihlar).
24. Pre-Clinical Assessment
of Drug-Induced QT Interval Prolongation. Current Issues and Impact on Drug Discovery (B. Fermini, A.A. Fossa).
VII. TRENDS AND
PERSPECTIVES
25. To Market, To Market-2003 (Shridhar Hegde, J. Carter).
| Bibliographic details |
Paperback, 448 pages, publication date: DEC-2004
ISBN-13: 978-0-12-040539-8
ISBN-10: 0-12-040539-3
Imprint: ACADEMIC PRESS
|
| Price and Ordering |
Price:
GBP 75
EUR 110
USD 150
|  |
Books and book related electronic products are priced in US dollars (USD), euro (EUR), and Great Britain Pounds (GBP). USD prices apply to the Americas and Asia Pacific. EUR prices apply in Europe and the Middle East. GBP prices apply to the UK and all other countries.
|
See also information about conditions of sale & ordering procedures, and links to our regional sales offices.
|
030/302
Last update: 27 Sep 2008
|
|
| |
| | |
|
|
| |
